Dear Sir,

March is Prostate Cancer Awareness Month.  In a few weeks time NICE will meet to discuss the responses to their draft decision not to recommend abiraterone, a life extending drug for men with incurable prostate cancer.

Read more

Jeremy Laurance raises an important issue about the balance of providing the best quality of care for all patients with value for money for the NHS [Why spare the drug companies? Friday 3 February].  However, we strongly dispute the claim that health charities like ours are helping to bankrupt the NHS by calling for patients to be given access to the treatments they need.

Read more